Endocrine therapy initiation among women with stage I-III invasive, hormone receptor-positive breast cancer from 2001-2016.

Erin J Aiello BowlesCody RaminDiana S M BuistHeather Spencer FeigelsonSheila WeinmannLene H S VeigaClara BodelonRochelle E CurtisJacqueline B VoAmy Berrington de GonzalezGretchen L Gierach

Published in: Breast cancer research and treatment (2022)

Despite an increase in AI use over time, at least one in six eligible women did not initiate endocrine therapy, highlighting opportunities for improving endocrine therapy uptake in breast cancer survivors.

Keyphrases

positive breast cancer
artificial intelligence
polycystic ovary syndrome
type diabetes
machine learning
adipose tissue
bone marrow
skeletal muscle
cell therapy